Skip to main content
. Author manuscript; available in PMC: 2018 Aug 1.
Published in final edited form as: Drug Deliv Transl Res. 2017 Aug;7(4):582–597. doi: 10.1007/s13346-017-0379-2

Fig. 6.

Fig. 6

The cytotoxic effects of doxorubicin, a mixture of doxorubicin and quercetin, or DoxQ determined by resazurin blue assay expressed as IC50 after 5 µM treatment for 72 h. N = 4; mean ± SD